Search Results - "VROUENRAETS, Maarten B"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy by Vrouenraets, Maarten B., Visser, Gerard W.M., Loup, Christophe, Meunier, Bernard, Stigter, Marijke, Oppelaar, Hugo, Stewart, Fiona A., Snow, Gordon B., van Dongen, Guus A.M.S.

    Published in International journal of cancer (01-10-2000)
    “…Coupling of photosensitizers to tumor‐selective monoclonal antibodies (MAbs) is an attractive option for improving the selectivity of photodynamic therapy…”
    Get full text
    Journal Article
  2. 2

    Basic principles, applications in oncology and improved selectivity of photodynamic therapy by Vrouenraets, Maarten B, Visser, Gerard W M, Snow, Gordon B, van Dongen, Guus A M S

    Published in Anticancer research (01-01-2003)
    “…Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumors. This review starts with a summary of the basic…”
    Get more information
    Journal Article
  3. 3

    Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies : Improved efficacy in photodynamic therapy by VROUENRAETS, Maarten B, VISSER, Gerard W. M, STIGTER, Marijke, OPPELAAR, Hugo, SNOW, Gordon B, VAN DONGEN, Guus A. M. S

    Published in Cancer research (Chicago, Ill.) (01-03-2001)
    “…The use of monoclonal antibodies (MAbs) directed against tumor-associated antigens for targeting of photosensitizers is an interesting option to improve the…”
    Get full text
    Journal Article
  4. 4

    Comparison of aluminium (III) phthalocyanine tetrasulfonate‐ and meta‐tetrahydroxyphenylchlorin‐monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro by Vrouenraets, Maarten B., Visser, Gerard W.M., Stigter, Marÿke, Oppelaar, Hugo, Snow, Gordon B., van Dongen, Guus A.M.S.

    Published in International journal of cancer (10-04-2002)
    “…A challenge in photodynamic therapy (PDT) is to improve the tumour selectivity of the photosensitizers by using monoclonal antibodies (MAbs). With this aim, we…”
    Get full text
    Journal Article
  5. 5

    Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy by VROUENRAETS, M. B, VISSER, G. W. M, STEWART, F. A, STIGTER, M, OPPELAAR, H, POSTMUS, P. E, SNOW, G. B, VAN DONGEN, G. A. M. S

    Published in Cancer research (Chicago, Ill.) (01-04-1999)
    “…A limitation of photodynamic therapy is the lack of tumor selectivity of the photosensitizer. To overcome this problem, a protocol was developed for coupling…”
    Get full text
    Journal Article